SUBSCRIBE
SUBSCRIBE
News   Drug Development

Takeda Pharmaceutical Co. Ltd. Starts Japan Phase III Trials for Obesity Drug

December 22, 2008 | 
1 min read

TOKYO, Dec 22 (Reuters) - Takeda Pharmaceutical Co Ltd said on Monday it has started late stage or Phase III clinical trials for its ATL-962 obesity drug in Japan.

Clinical research Phase III Asia
Takeda
MORE ON THIS TOPIC
istock/ArtemisDiana
PARTNERED
Where AI Adds Real Value in Clinical Development
May 12, 2025
 · 
7 min read
 · 
BioSpace Insights
Drug Development
Eroding Immunity: Vaccine Hesitancy and Cynicism With Paul Offit
May 8, 2025
 · 
1 min read
 · 
Lori Ellis
Computational Biology - The Study of Biological Systems Through Computational Techniques and Modeling - Conceptual Illustration
Gene therapy
CRISPR’s Casgevy on the Rise With More Gene Therapy Proof of Concept To Come in 2025
May 7, 2025
 · 
4 min read
 · 
Annalee Armstrong
Workplace conflict Job rivalry, jealousy among colleagues concept, angry coworker fighting by pulling golden crown metaphor of job promotion position.
Cancer
Summit’s Campaign To Conquer Keytruda Nears First Global Phase III Data
May 7, 2025
 · 
5 min read
 · 
Nick Paul Taylor